Written Question·Department of Health and Social Care·UIN 55821

Drugs: Licensing

Tabled: 30 May 2025

Answered: 6 June 2025

Question

Kevin McKenna

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the the approval process of (a) high tariff drugs (b) the use of Obinutuzumab in patients with lupus who have experienced severe infusion reactions with rituximab.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations on whether new licensed medicines, including high cost medicines, should be routinely funded by the National Health Service in England, based o...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 55821) →